Schrodinger, Inc. (NASDAQ:SDGR)
| Market Cap | 2.26B+58.9% |
| Revenue (ttm) | 259.04M+8.9% |
| Net Income | -54.34M+70.0% |
| EPS | -0.74+70.2% |
| Shares Out | 74.72M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,949,590 |
| Open | 24.09 |
| Previous Close | 23.93 |
| Day's Range | 24.09 - 30.41 |
| 52-Week Range | 10.95 - 30.41 |
| Beta | 1.69 |
| Analysts | Buy |
| Price Target | 19.00(-37.17%) |
| Earnings Date | Nov 4, 2026 |
Schrodinger, Inc. has a live Insider Score.
Scored on 0 qualifying trades from 0 insiders in the last 90 days.
About SDGR
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$SDGR stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in SDGR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SDGR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SDGR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
SDGR Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New SDGR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SDGR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SDGR
| ETF | Est. Holding Size |
|---|---|
| ARKGARK Genomic Revolution ETF | $50.70M |
| VTIVanguard Morningstar Total Stock Market ETF | $38.32M |
| IWMiShares Russell 2000 ETF | $35.86M |
| VBVanguard Morningstar Small-Cap ETF | $27.86M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $16.01M |
| IWOiShares Russell 2000 Growth ETF | $13.03M |
Estimated from each fund’s disclosed top holdings × AUM
SDGR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SDGR’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score